Blog Posts by Tag: Oncology
Considerations When Selecting an LIS for Gynecologic Cytology and Molecular Testing
Laboratories leaders investigating LIS solutions for Gynecologic Cytology and Molecular testing need dynamic solutions that meet all productivity and efficiency goals and regulatory requirements. Other essential factors include cytotech reporting, automated quality control review and reporting, pathology oversight and reporting, Bethesda reporting guidelines, management reporting, lookback...
Pathology Laboratories Need Unique LIS Capabilities
Anatomic pathology laboratories receive multiple specimen types including pathology, IHC, molecular, next-gen sequencing, FLOW, cytogenetics, FISH, clinical trials, and specialty testing. This is why anatomic pathology laboratories require a sophisticated laboratory information system (LIS) with enhanced capabilities that can manage everything from routine to highly complex cases. The right...
How to Increase Clinical Trial Participation in Community Oncology
In November, I co-authored an article in Oncology Practice Management with Randy Erickson, RN, MBA, Chief Executive Officer of Utah Cancer Specialists, Johnny Walker, Director of Research of Utah Cancer Specialists, and Linh Mekuria, MPA, clinical informaticist with XIFIN, Inc. The article, titled “Increasing Clinical Trial Participation in the Community,” explores the structural barriers to...
Using Real-World Data for Oncology Treatment
Last year, I had the pleasure of co-authoring an article in Oncology Practice Management with Randy Erickson, RN, MBA, Chief Executive Officer of Utah Cancer Specialists, Nitin Chandramouli, MD, FACP, President of Utah Cancer Specialists, and Linh Mekuria, MPA, clinical informaticist with XIFIN, Inc. The article, titled “Treatment Patterns and Prescribing Practices Based on Real-World Data”...
My Predictions for the Coming Year: A New Blueprint for Healthcare
These past two years have been a period of change, during which COVID dramatically shifted the focus to the importance of diagnostic testing. In fact, with the Omicron surge putting a further spotlight on the fact that testing is still needed even with widespread vaccinations, TIME has labelled 2022 “the year of testing.” Alongside this increased focus, however, are ongoing financial and...
Integrating Informatics for Clinical-Genomic Collaboration and Analysis
I recently had the pleasure of co-authoring an article in Oncology Practice Management. The article, titled “An Integrated Informatics Approach for Clinical-Genomic Knowledge Sharing and Analysis” outlines the design of a real-time registry that aggregates heterogeneous clinical and genomic data (along with other molecular results) in a unified structure to identify, vet, and fulfill...